Background-Atrial mechanical stunning due to atrial fibrillation may persist after restoration of sinus rhythm. Although the mechanism of rapid rate-related contractile dysfunction remains unknown, ischemia, pH changes, and calcium overload have been postulated as potential mechanisms. We hypothesized that blockade of the Na ϩ /H ϩ exchanger (NHE) would alter atrial contractile dysfunction from rapid rates. Methods and Results-Twenty-three anesthetized dogs were studied and subjected to 5 hours of rapid right atrial pacing.
D espite prompt restoration of sinus rhythm, even brief periods of atrial fibrillation (AF) can cause atrial contractile dysfunction, 1 which can last for days and contribute to the risk of cardioembolic events after successful cardioversion to sinus rhythm. [2] [3] [4] The mechanism for this AF-induced atrial contractile abnormality is currently unknown. Ischemia, changes in pH, and intracellular calcium overload have been hypothesized to be important factors for this mechanical "stunning."
Previous studies have demonstrated the efficacy of Na ϩ /H ϩ exchanger (NHE) inhibitors (NHEIs) in the prevention of ischemia-induced stunning in the ventricle. [5] [6] [7] We previously reported that electrical remodeling due to rapid rates in the atrium could be prevented with blockade of the NHE, suggesting a potential role for alterations in intracellular pH as one contributing factor. 8 The purpose of this study was to test the hypothesis that selective blockade of the cardiac NHE-1 isoform with the specific NHE blocker (HOE642) would alter the rapid deterioration in atrial contractile function due to rapid rates imposed by AF.
Methods
The experiments performed in this study were approved by the Institutional Animal Care and Use Committee of Indiana University and were in accordance with the Guide for Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication No. 86-23, revised 1985) . Twenty-three adult mongrel dogs (21 to 29 kg) were anesthetized with a bolus dose of thiopental sodium (20 mg/kg IV), intubated, and placed on mechanical ventilation with a volume-cycled ventilator (Ohio Medical Products). Anesthesia was maintained with 1.0 to 2.0 vol% isoflurane. Introducer sheaths were inserted in the right femoral vein and the right femoral artery for venous access and for continuous blood pressure monitoring, respectively. The heart was exposed via left thoracotomy and suspended in a pericardial cradle. Two plunge electrodes were placed in the right atrial appendage for bipolar pacing.
A pair of sonomicrometer transducers (2.5 mm in diameter) (Triton Technology) were sewn into position on the medial and lateral aspects of the left atrium. The sonomicrometer signals were displayed on an oscilloscope, digitized, and recorded by PCcompatible computer for later analysis (WINDAQ/Pro software, DATAQ Instruments). Atrial contractile measurements were analyzed as described by Hoit et al. 9 Minimum left atrial diameter (LAd min ) was taken at the end of atrial systole as reflected in the atrial pressure tracing and was correlated with the surface ECG. Maximum left atrial diameter (LAd max ) occurred at the time of mitral valve opening, corresponding to the time of the V wave of the atrial pressure tracing. An 8F introducer sheath was placed in the right internal jugular vein, through which a 7.5F fluid-filled triple-lumen flotation catheter was inserted to monitor intracardiac pressures (Baxter). A 5.0-MHz omniplane TEE probe (Hewlett Packard) was used for measurement of the peak systolic left atrial appendage contraction velocity (LAACV) (cm/s) by pulsed-wave Doppler analysis, as described by Tabata et al. 2 The LAACV was measured with the sample volume 1 cm from the LAA orifice leading into the left atrial main chamber in a transverse view that included the left atrial main chamber and the LAA. The LAACV was the maximal systolic velocity recorded during a cardiac cycle. Baseline hemodynamic, LAACV, and atrial contractile measurements were recorded in sinus rhythm.
Ten dogs (NHEI group) received a maximally effective intravenous bolus dose of HOE642 (2 mg/kg) (Hoechst Marion Roussel), 10 dogs (control group) received an equivalent volume of saline, and 3 dogs received an intragastric suspension of rapid-onset nifedipine (1 mg/kg) (nifedipine group) with equivalent intravenous saline placebo. The dogs were observed for 30 minutes, and then repeat measurements of the previously mentioned parameters were performed. Rapid right atrial pacing was then initiated at 600 bpm with a pacing output of twice diastolic threshold. Data points were acquired in sinus rhythm, after temporary cessation of rapid atrial pacing, at 15-minute intervals for the first hour and then hourly for a total of 5 hours. Pacing was discontinued for no longer than 1 minute during acquisition of data and was immediately resumed after measurements were obtained.
Data were analyzed offline. A total of 10 sets of atrial contractile data (LAd max and LAd min , in millimeters) and peak systolic LAACVs were measured during sinus rhythm and averaged for each time interval. The percentage of left atrial fractional shortening (LAFS) was calculated as the mean (LAd max ϪLAd min /LAd maxϫ 100) at each time interval.
Statistical Analysis
Values are presented as meanϮSD. Comparisons among groups were made with ANOVA and a Fisher's protected least significant difference post hoc test. Probability values of Pϭ0.05 were considered significant. Comparisons within each group at different time points were made by ANOVA with repeated measures.
Results

Left Atrial Fractional Shortening
At baseline, there was no significant difference in LAFS among the 3 groups (control 23.0Ϯ5.5%, NHEI 24.3Ϯ5.3%, nifedipine 18.3Ϯ3.4%, Pϭ0.200) ( Figure 1 ). After 15 minutes of pacing, LAFS decreased in the control group Ϸ31% from baseline values to 15.8Ϯ6.5% (Pϭ0.001) ( Figure 1 ). At 45 minutes, LAFS had decreased to 10.3Ϯ6.4% (Pϭ0.01). This trend continued and reached a plateau at 180 minutes, where the LAFS value had decreased Ϸ68% from baseline to 7.3Ϯ3.9% (PϽ0.03). Further loss of LAFS was not noted with continuation of pacing beyond 180 minutes. At 300 minutes of pacing, LAFS was 7.3Ϯ4.2%.
In contrast to the control group, the NHEI group showed significantly less decline in left atrial contractile function ( Figure 1 ). By 15 minutes, LAFS had decreased only Ϸ13% from baseline values to 21.0Ϯ4.5% (Pϭ0.05). At 45 minutes, LAFS decreased to 19.1Ϯ4.4% (Pϭ0.001) compared with control. The degree of decrement in LAFS was more gradual in the NHEI group, such that LAFS at 180 minutes had decreased only Ϸ29% from baseline to 17.2Ϯ5.2% (PϽ0.0001). At the conclusion of pacing, LAFS (15.3Ϯ5.3%) was still significantly preserved at 37% from baseline (Pϭ0.0009). Significant differences in LAFS be- tween the control group and the NHEI group (Pϭ0.05) were noted at every time interval after the initiation of pacing.
The findings in the nifedipine group were very similar to those of the control group (Figure 1 ). After 15 minutes of pacing, LAFS decreased Ϸ39% from baseline values to 11.1Ϯ3.8%. At 15 minutes, this value was significantly lower than that of the NHEI group (Pϭ0.01) but was not different from controls. At 45 minutes, LAFS had decreased further to 7.4Ϯ3.0%. This too was significantly lower than that in the NHEI group (Pϭ0.003) but not different from controls. A progressive loss of atrial contractile function, similar to that in the control group, was noted throughout the duration of pacing. At the conclusion of 300 minutes of pacing, LAFS had decreased Ϸ79% from baseline values to 3.9Ϯ1.3%, which was significantly different from the NHEI group (Pϭ0.001).
LAFS was significantly lower in the nifedipine group at all time intervals after the initiation of pacing than in the NHEI group (Pϭ0.05). LAFS in the nifedipine group was never significantly different from the control group (PϾ0.05) at any time interval after initiation of pacing.
Left Atrial Appendage Contraction Velocity
At baseline, there was no significant difference in LAACV among the 3 groups (control 56.1Ϯ21.0 cm/s, NHEI 48.5Ϯ11.2 cm/s, nifedipine 42.8Ϯ3.3 cm/s, Pϭ0.42) ( Figure  2 ). After 15 minutes of pacing, LAACV in the control group decreased Ϸ21% from baseline values to 43.7Ϯ16.5 cm/s (Pϭ0.002) ( Figure 2 ). At 45 minutes, LAACV had decreased to 36.2Ϯ15.6 cm/s (Pϭ0.001). This abrupt downward trend continued and reached a plateau at 120 minutes, when the LAACV value had decreased Ϸ49% from baseline values to 27.5Ϯ10.9 cm/s (PϽ0.0001 versus the NHEI group). At 300 minutes, LAACV was 24.7Ϯ6.6 cm/s.
In contrast to the control group, at 15 minutes of pacing, the NHEI group displayed minimal reduction (6%) in LAACV from baseline values to 45.1Ϯ9.8 cm/s (Pϭ0.01) ( Figure 2 ). The LAACV in the NHEI group (41.9Ϯ8.2 cm/s) was significantly greater than that in controls at 45 minutes (Pϭ0.0004). The degree of decrement in LAACV in the NHEI group was more gradual; at 180 minutes, LAACV had decreased 19% from baseline to 37.9Ϯ6.3 cm/s (PϽ0.0002 versus the control group). At the conclusion of pacing, LAACV at 29.9Ϯ7.1 cm/s (Pϭ0.006) was still significantly preserved at 36% from baseline compared with the control group. Significant differences in LAACV between the control group and the NHEI group (Pϭ0.05) were noted at every time interval after initiation of pacing.
The findings in the nifedipine group were very similar to those of the control group. After 15 minutes of pacing, LAACV decreased Ϸ24% from baseline values to 32.5Ϯ5.6 cm/s. At 15 minutes, this value was significantly lower than that of the NHEI group (Pϭ0.03) (Figure 2) . At 45 minutes, LAACV had decreased significantly compared with the NHEI group to 25.7Ϯ3.9 cm/s (Pϭ0.003). This progressive loss of contractile function was noted throughout the duration of the pacing. At 300 minutes, LAACV had decreased Ϸ52%. Significant differences in LAACV between the nifedipine and NHEI groups (Pϭ0.05) were noted at every time interval after initiation of the pacing, except at 300 minutes (Pϭ0.08). LAACV was not significantly different between the nifedipine and control groups at any time interval.
Analyses of hemodynamic data are shown in Figures 3 and  4 . The mean arterial pressure (MAP) in the nifedipine group at 30 minutes after drug was significantly lower than in the control group (Pϭ0.007). Otherwise, no significant differences were noted in MAP or pulmonary capillary wedge pressure (PCWP). There were no significant differences in heart rate at any time among the 3 groups.
Discussion
In this study, we demonstrated that the decline in atrial mechanical function after rapid atrial pacing in dogs, evaluated by pulsed-wave Doppler echocardiography and direct measurement of atrial contractile function, is blunted by selective blockade of the cardiac NHE-1 isoform. The degree of atrial mechanical dysfunction noted in the NHEI group was significantly blunted throughout the duration of pacing, showing only gradual decrement of atrial contractile function over time. In contrast to the NHEI group, we found that the control and nifedipine groups both exhibited significant abrupt losses of atrial contractile function ("stunning") immediately after the initiation of pacing. Atrial contractile function in these 2 groups continued to decrease significantly, compared with the NHEI group, with increasing duration of pacing. The only significant difference noted when hemody-namic data were analyzed was between the nifedipine and control groups at 30 minutes after drug.
One potential mechanism for atrial mechanical dysfunction or stunning may be intracellular acidosis, perhaps secondary to rapid rate-induced increases in oxygen consumption in the setting of an overall reduction in atrial flow reserve. Reduction of flow reserve coupled with increased metabolic demand could potentially lead to atrial ischemia. Whereas the NHE is relatively inactive at normal intracellular pH, it is primarily (but not absolutely) activated during intracellular acidosis. 10, 11 Activation of the cardiac NHE leads to an exchange of intracellular hydrogen ions for extracellular Na ϩ ions. The resulting influx of Na ϩ ions alters the reversal potential of the Na ϩ /Ca 2ϩ exchanger in a manner that inhibits Ca 2ϩ efflux and/or enhances Ca 2ϩ influx through this bidirectional mechanism, leading to a pathological increase in intracellular Ca 2ϩ . HOE642 is likely to afford a cardioprotective effect by inhibiting this sequence at an early stage through the limitation of Na ϩ influx. In fact, evidence suggests that HOE642 attenuates Ca 2ϩ overload during ischemia and early reperfusion. 12 Although an ischemic mechanism is plausible, preliminary data from our laboratory and from others suggest that oxidative metabolism is not altered (as measured by high-energy phosphates) during either shortterm or long-term rapid atrial pacing. [13] [14] [15] These studies did not directly measure intracellular pH, however, which is the primary mode by which the NHE is activated.
Another potential explanation for our findings may be that the NHE is activated earlier (without acidosis) by other mechanisms. Rapid atrial pacing may lead to sympathetic activation with release of neurotransmitters (eg, epinephrine, norepinephrine) and mechanical stimulation, which may trigger the discharge of vasoactive peptides (eg, atrial natriuretic peptide, angiotensin II). In addition to intracellular acidosis, it has been demonstrated that a number of other mediators can stimulate NHE activity or shift the pH i dependence of the NHE. Both norepinephrine and epinephrine have been shown to activate the NHE in cardiac cells. 16, 17 Jayachandran et al 18 showed that sympathetic innervation and norepinephrine content are increased after rapid atrial pacing. ATP, endothelin, and angiotensin II also affect cardiac NHE activity. 19 -21 Thus, during high-rate pacing or a high-energy metabolic state, these may serve as adjunctive mechanisms resulting in NHE activation and ultimately lead to atrial contractile dysfunction.
The heart regulates pH i closely under normal physiological conditions. Studies of isolated ventricular myocytes have demonstrated that contractility is affected negatively by a decrease in pH i and somewhat positively by an increase in pH i . 20, 22, 23 Rapid atrial rates during pacing may lead to enhanced cellular metabolism and activation of the neurohormonal milieu. These changes could potentially lead to a rise in H ϩ , CO 2 , and HCO 3 Ϫ generation, in turn altering pH i and leading to early activation of the NHE. This may be another factor accounting for the preservation of atrial contractile function in the NHEI group.
Multiple studies have demonstrated the effectiveness of NHE inhibitors on ventricular contractile dysfunction during ischemia, infarction, and reperfusion. 5,24 -26 HOE42 has been shown to attenuate ventricular contractile dysfunction (stunning) and improve recovery of ventricular contractility during ischemia and after reperfusion. [5] [6] [7] To date, few data exist regarding the effect of NHE inhibitors on the atrium, although Jayachandran et al 8 showed that electrical remodeling due to rapid rates in the atrium could be prevented with blockade of the NHE, suggesting a potential role for alterations in pH i as a contributing factor.
Consistent with the findings in our control group, multiple studies have shown that even brief periods of AF in normal canine hearts result in marked atrial systolic dysfunction after a brief period of hypercontractility. 3, 13 We did not observe this brief hypercontractility, because our first time point was significantly longer than the 5 minutes used in a previous study. 13 Blockade of L-type calcium channels with verapamil has been demonstrated to reduce the degree and duration of postfibrillation atrial contractile dysfunction. 1, 13 Furthermore, specific blockade of T-type Ca 2ϩ channels with mibefradil has been demonstrated to attenuate atrial electrophysiological remodeling by atrial tachycardia, 27 thus potentially contributing to inhibition of atrial stunning due to rapid atrial rates. Because verapamil has other cardiac pharmacological actions, such as sodium channel blockade, 28 however, it remains unclear whether the blunting effect of verapamil is solely due to L-type Ca 2ϩ channel blockade. We analyzed the efficacy of rapid-onset nifedipine because unlike verapamil, it is a pure L-type Ca 2ϩ channel blocker at therapeutic levels. 29, 30 Studies performed in dogs showed that therapeutic levels of nifedipine could be rapidly achieved and maintained over a 6-hour period with this oral preparation at 1 mg/kg. 31, 32 In contrast to previous studies, our data reveal that specific blockade of the L-type Ca 2ϩ channel with nifedipine did not blunt AFinduced atrial mechanical dysfunction.
The present study suggests that HOE642 may have some utility to attenuate atrial contractile dysfunction after cardioversion of even brief periods of AF. Because human AF is quite different from the animal model used in this study, further studies will be needed to evaluate the possible benefit of these findings in humans with AF. In addition, the influence of structural and degenerative atrial changes (observed even in patients with lone AF) 33-35 on postcardioversion stunning is not known.
Limitations
Although HOE642 is a highly specific blocking agent of the cardiac NHE, other pharmacological actions cannot be excluded. Previous studies have shown a lack of effect of this drug on the Na ϩ current as well as the Na ϩ /Ca 2ϩ exchanger. 36 In the present study, HOE642 had no effect on atrial contractile function at baseline, suggesting a lack of direct actions at baseline. Mathur and Karmazyn 37 showed that HOE642 in combination with isoflurane produced an additive beneficial effect on left ventricular function and led to preservation of ATP levels. Although the effects of isoflurane on atrial contractile function are unknown, no significant effect was noted during isoflurane anesthesia at baseline, and the rate of isoflurane administration was held constant in all groups during the study.
Although the oral route has been demonstrated to be an effective method of nifedipine administration, leading to rapid and sustained therapeutic drug levels 31, 32 adequate to achieve blockade of L-type Ca 2ϩ channels, we cannot ensure that complete blockade of atrial L-type Ca 2ϩ channels was achieved throughout the experiment. In addition, it is possible that increased autonomic tone may have prevented nifedipine-related changes and possibly have accounted for the lack of blunting of atrial contractile dysfunction noted in this group. This may potentially explain the lack of effectiveness of nifedipine in our study compared with that of verapamil in previous studies. 13 Finally, although we evaluated the time course of deterioration of atrial contractile function from rapid rates, the length of the study precluded us from fully evaluating the recovery of contractile function after the cessation of rapid atrial pacing.
Conclusions
Loss of atrial mechanical function from prolonged rapid atrial rates is blunted by blockade of the cardiac NHE. These preliminary observations strongly suggest that the cardiac NHE may be a factor in the pathophysiology of atrial contractile dysfunction after acute episodes of AF. Further investigations will be necessary to fully elucidate the mechanism and clinical implications of this finding.
